Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme. - Wikidata - awgldk - TriplyDB

Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme.

Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme.

http://www.wikidata.org/entity/Q34722857

about

Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting Severity, etiology and possible consequences of treatment-related lymphopenia in patients with newly diagnosed high-grade gliomas Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma.The Sequence of Delta24-RGD and TMZ Administration in Malignant Glioma Affects the Role of CD8+T Cell Anti-tumor Activity.Antibody-based immunotherapy for malignant glioma.T-cell subsets in peripheral blood and tumors of patients treated with oncolytic adenoviruses.Regulatory T cells are not a strong predictor of survival for patients with glioblastoma.Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model Recent developments on immunotherapy for brain cancer.High leukocyte mitochondrial DNA content contributes to poor prognosis in glioma patients through its immunosuppressive effect Impact of temozolomide on immune response during malignant glioma chemotherapy The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma.A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma Temozolomide does not impair gene therapy-mediated antitumor immunity in syngeneic brain tumor models.Vaccine strategies for glioblastoma: progress and future directions.Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours Vaccine-based immunotherapy for glioblastoma.Therapeutic potential and challenges of natural killer cells in treatment of solid tumors The role of regulatory T cells and microglia in glioblastoma-associated immunosuppression.Immune microenvironment of gliomas.Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells.Immunological effects of chemotherapy and radiotherapy against brain tumors.Immunophenotypic characterization of CD45RO+ and CD45RA+ T cell subsets in peripheral blood of peripheral T cell lymphoma patients.Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival.NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination.Complete response to temozolomide in chronic lymphocytic leukemia.Alkylating chemotherapy may exert a uniquely deleterious effect upon neo-antigen-targeting anticancer vaccination.Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma.Immunotherapies for malignant glioma.Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response.Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide.Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors.Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients.In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment.Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors

P2860

Q26742012-18B231FD-52F9-41FE-B174-47E2CF536C3E Q26862551-C688B560-FF95-4F2D-9CBA-47F84AF58FA2 Q30275254-8C46B72E-82B1-4733-AF32-A97F3E0A3A4B Q33633272-0E961E0F-479B-46EB-AD7B-FCEF029380ED Q34120472-4F72641C-1C5E-4991-8EFB-25427365E392 Q35594838-91819D37-CD5B-419F-B457-14926DCB72EF Q35789008-632B9A39-A29D-4457-8810-2B23B472FF98 Q35909751-9BC91E5B-5559-48EE-A6A0-908FAA0F033E Q35992355-4D38B385-FDB3-489E-886F-02800B8D0915 Q36286718-225E53DE-4A81-4316-BEA3-36BA276D30EC Q36362798-FE6D0469-F67C-4FA6-9C00-7B3E2E6B062C Q37012579-FDD3B985-B6CD-4756-8FB0-D97AB3011ECB Q37262109-33907A4C-0537-4925-B4A5-5C60F0339102 Q37647868-3568E283-BC2A-4952-8F99-B994A48A7B68 Q38081910-2BA5B6F1-843C-467F-B6DE-59051546FF35 Q38148501-F0B2AAF7-26CA-4A85-B946-01F1D72D66DB Q38233114-E706C829-AB28-41A1-9FCF-E767313BEA43 Q38478878-6053A67D-0409-4F86-A109-A7C129A8D54A Q38540262-951DA0B4-C7CF-4EEB-B797-C934EE72BC6D Q38712457-78F8535C-26A3-46C3-AAFD-9295B075C449 Q38943301-ACCF96EA-0442-473A-BFB1-5BC40BEDEB47 Q38947116-C827B489-8D6E-4FF7-8267-1D1C28B59319 Q39190130-96775A9C-3D5E-479D-82CD-01D75073D510 Q39195033-804DA1DA-39C6-46EE-B7A4-9832418256C2 Q39798606-B21D389A-54C9-4481-AA4B-247B4D736386 Q40241735-066E9ABF-7F8B-48A8-B87F-FB62AF4004E6 Q40981068-44C3143D-FC86-4141-A029-DF09D4AF2C53 Q42177990-7331D2A4-909B-4689-B43F-86BD802DA0AE Q47773621-1D6E8673-9386-453A-9110-5B3ECD8E6ACB Q47915209-48DF7F88-87EB-457F-A122-00B5B9B018B6 Q48280437-A3289422-E03D-4D8D-9877-21427986A313 Q48325020-5B700487-DF5B-4863-921C-0EBC29F4AF72 Q48503168-E55A84FD-7872-4A97-8BA4-E8E0DD010D52 Q50927368-FA48E9B8-DEC9-4289-9005-D1075461C479 Q52780147-D4520C65-8547-48E0-A7E8-5ED1AA8462B2 Q58119192-AC74C18D-7A3F-4290-AB97-C1AB63742168

P2860

Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme.

http://www.wikidata.org/entity/Q34722857

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Immune modulation effects of c ...... with glioblastoma multiforme.

@ast

Immune modulation effects of c ...... with glioblastoma multiforme.

@en

Immune modulation effects of c ...... with glioblastoma multiforme.

@nl

type

label

Immune modulation effects of c ...... with glioblastoma multiforme.

@ast

Immune modulation effects of c ...... with glioblastoma multiforme.

@en

Immune modulation effects of c ...... with glioblastoma multiforme.

@nl

prefLabel

Immune modulation effects of c ...... with glioblastoma multiforme.

@ast

Immune modulation effects of c ...... with glioblastoma multiforme.

@en

Immune modulation effects of c ...... with glioblastoma multiforme.

@nl

P1433

Q34722857-55CBB0BC-1E12-44E5-87A6-FF5792807D88

P1476

Q34722857-5E4E13B0-E2DD-4261-BD68-6D07FC7FC34E

P2093

Q34722857-153ADDB2-04E5-4983-98DF-9F37911972CA

Q34722857-83111B3B-2C65-4E64-A16D-614461DA6C85

Q34722857-A1D1E29F-C332-45E4-B92F-6D13DC78C9E2

Q34722857-E72204DA-2DE9-437E-885F-331AE25BC9F5

Q34722857-F2BD805F-B993-4661-9041-0F31ECF15FEE

P2860

Q34722857-05DEC6E6-AFD9-4E68-AA21-935707A3AAC7

Q34722857-0640FD72-6411-4A2C-B073-EA8DC38F0F2C

Q34722857-151E114E-0E8D-4445-BCFE-B2884851ED8F

Q34722857-181F3B7F-6033-40B8-97EA-10AD41B3D27F

Q34722857-1A8F4E13-A092-49A4-9358-977AEFF8348A

Q34722857-3C7C62B5-77B6-4477-90B3-8CEBA0677610

Q34722857-3CBF38F6-E34D-45B9-902D-DC945FCA6D60

Q34722857-4ED75A10-AC83-46F5-9FBA-8C0F273EA50B

Q34722857-559D342E-F5CE-47E4-9531-7200A81BEBC4

Q34722857-5C0BEFCA-C885-413A-ABF4-B78136B8907F

P304

Q34722857-2AC8F0D9-FBAD-4F4A-8413-3D780AA6024D

P31

Q34722857-57D35D11-CB48-41BE-A606-D446AA700FDC

P356

Q34722857-77DD3D89-45AA-441A-AA7C-23DFD4F38A40

P433

Q34722857-BBA6C330-F131-4529-A24D-95A539FA1DC6

P478

Q34722857-D82A5180-F663-4C09-8A78-58796ED03B42

P50

Q34722857-3F75B942-2214-4F41-82DB-501F56BAFD3D

P577

Q34722857-2749ABB9-0347-4ABA-81EA-D12D1FFAAA2B

P5875

Q34722857-60BEDC71-3C8F-4CEA-9EFC-B77D9BB67EEC

P698

Q34722857-3D247EE3-25B5-4C67-8AC9-BAFFDDF9A414

P921

Q34722857-31D3E467-A14D-48F4-9992-29CC959B3BB5

Q34722857-44209A70-ABD3-4028-A1C4-52E442548432

P932

Q34722857-8BACFD1C-85D4-43D7-A9F5-7C761EE233A8

P356

P1433

P1476

Immune modulation effects of c ...... with glioblastoma multiforme.

@en

P2093

Anik L Côté

http://www.w3.org/2001/XMLSchema#string

Camilo E Fadul

http://www.w3.org/2001/XMLSchema#string

Jan L Fisher

http://www.w3.org/2001/XMLSchema#string

Jiang Gui

http://www.w3.org/2001/XMLSchema#string

Marc S Ernstoff

http://www.w3.org/2001/XMLSchema#string

P2860

Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications.

Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties.

Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.

Mechanisms of malignant glioma immune resistance and sources of immunosuppression

Pharmacologic induction of CD8+ T cell memory: better living through chemistry

Antigen-specific CD4+ regulatory T cells in cancer: implications for immunotherapy.

Human regulatory T cells and their role in autoimmune disease.

P304

393-400

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOQ204

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Thomas H Hampton

P577

2011-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49853287

http://www.w3.org/2001/XMLSchema#string

P698

21339188

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

3064696

http://www.w3.org/2001/XMLSchema#string